DE60206270D1 - Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung - Google Patents

Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Info

Publication number
DE60206270D1
DE60206270D1 DE60206270T DE60206270T DE60206270D1 DE 60206270 D1 DE60206270 D1 DE 60206270D1 DE 60206270 T DE60206270 T DE 60206270T DE 60206270 T DE60206270 T DE 60206270T DE 60206270 D1 DE60206270 D1 DE 60206270D1
Authority
DE
Germany
Prior art keywords
extract
inflammatory
compositions contain
modulating inflammation
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60206270T
Other languages
English (en)
Other versions
DE60206270T2 (de
Inventor
Alain Andersen
Elyse Bissonnette
Rejean Drouin
Marc Purcell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purecell Technologies Inc
Original Assignee
Purecell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002381830A external-priority patent/CA2381830A1/en
Application filed by Purecell Technologies Inc filed Critical Purecell Technologies Inc
Application granted granted Critical
Publication of DE60206270D1 publication Critical patent/DE60206270D1/de
Publication of DE60206270T2 publication Critical patent/DE60206270T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60206270T 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung Expired - Lifetime DE60206270T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30183201P 2001-07-02 2001-07-02
US301832P 2001-07-02
CA002381830A CA2381830A1 (en) 2002-04-15 2002-04-15 Compositions comprising thylakoids useful in the modulation of the inflammation process
CA2381830 2002-04-15
PCT/CA2002/001009 WO2003004042A1 (en) 2001-07-02 2002-07-02 Compositions comprising thylakoids useful in the modulation of the inflammation process

Publications (2)

Publication Number Publication Date
DE60206270D1 true DE60206270D1 (de) 2006-02-02
DE60206270T2 DE60206270T2 (de) 2006-08-17

Family

ID=25682856

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60206270T Expired - Lifetime DE60206270T2 (de) 2001-07-02 2002-07-02 Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung

Country Status (6)

Country Link
US (1) US7329423B2 (de)
EP (1) EP1401463B1 (de)
JP (2) JP4988144B2 (de)
AT (1) ATE304860T1 (de)
DE (1) DE60206270T2 (de)
WO (1) WO2003004042A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070036877A1 (en) * 2003-09-22 2007-02-15 Marc Purcell Oral compositions and route of administration for the delivery of a thylakoid extract
PL1893224T3 (pl) * 2005-06-10 2018-10-31 Thylabisco Ab Stosowanie błon komórki roślinnej do leczenia otyłości
CA2644616A1 (en) * 2006-03-27 2007-10-04 Les Technologies Biofiltre Inc. Plant extracts and uses thereof in filter systems
JP5602164B2 (ja) * 2010-01-26 2014-10-08 株式会社日清製粉グループ本社 抗炎症剤
CA2699676C (en) 2010-04-12 2018-07-17 Purgenesis Technologies Inc. The use of a photosynthetic cell extract in a cosmetic composition
GB201304626D0 (en) * 2013-03-14 2013-05-01 Univ Cardiff Method of identifying a bacterial infection
CA3002679A1 (en) * 2015-11-03 2017-05-11 Groupe Sante Devonian Inc. Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease
CA3039681A1 (en) * 2016-11-04 2018-05-11 Groupe Sante Devonian Inc. Composition comprising thylakoid extract for use in the prevention and/or treatment of cardiovascular diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2293852A1 (fr) * 1999-12-30 2001-06-30 Purecell Technologies Inc. Procede de preparation d'extraits de plantes actifs et utiles a la capture de radicaux libres; les extraits, et compositions et dispositifs les comprenant

Also Published As

Publication number Publication date
JP2009298810A (ja) 2009-12-24
DE60206270T2 (de) 2006-08-17
JP4988144B2 (ja) 2012-08-01
US7329423B2 (en) 2008-02-12
EP1401463A1 (de) 2004-03-31
ATE304860T1 (de) 2005-10-15
WO2003004042A1 (en) 2003-01-16
JP2004535458A (ja) 2004-11-25
EP1401463B1 (de) 2005-09-21
US20050048148A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
DE69837393D1 (de) Stimulierung von hämatopoietischen zellen im vitro
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
ATE274330T1 (de) Gleitschutz fur einen gehäusekopf medizinischer instrumente
PA8481501A1 (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
BR0215405A (pt) Composições e processos de uso de collajolie
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
DE60206270D1 (de) Zusammensetzungen enthaltend thylakoids zur modulierung der entzündung
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
DK1019490T3 (da) Fremgangsmåder til modulering af hæmatopoese og vaskulær vækst
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
BR9711046A (pt) Ligando relacionado a fator de necrose de tumor.
ES2188870T3 (es) Sustrato compuesto elastomero selectivamente conductor segun el eje z, reutilizable.
ES2186803T3 (es) Peptidos tio-sustituidos como inhibidores de metaloproteinasas y de la liberacion de tnf.
ATE345769T1 (de) Selbstbräunende zusammensetzungen , die dha und propolis-extrakt enthalten
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
BR0205329A (pt) Composição lìquida formadora de pelìcula
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
ATE297903T1 (de) Substituierte phenyluracile
ES2111175T3 (es) Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias.
BRPI0518478A2 (pt) composiÇço de verniz para uso cosmÉtico ou farmacÊutico e utilizaÇço de solvente de origem vegetal

Legal Events

Date Code Title Description
8364 No opposition during term of opposition